Lonza Announces Price Increase for Niacin and Niacinamide

13.10.2005, Lonza announces a worldwide price increase of 10-12% for Niacin and Niacinamide feed grade due to continued price increases of raw materials, energy and transportation costs.
Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.18 billion in 2004. Headquartered in Switzerland, Lonza operates 18 production and R&D sites around the world. Its 5700 employees are passionately com-mitted to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharma-ceuticals for the pharmaceutical and agrochemical industries. On the basis of organic chemical, oleochemical and biotechnology platforms, Lonza creates value-added solu-tions for the nutrition, hygiene & personal care, wood & water treatment and industrial specialty markets. Lonza also offers polymer intermediates, resins and compounds. Further information can be found on our website www.lonza.com.
For further information:
Ernesto Plozza Business Unit Nutrition Tel +41 61 316 8638 Fax +41 61 316 9638 ernesto.plozza@lonza.com
Werner H. Grauwiler Corporate Communications Tel +41 61 316 8361 Fax +41 61 316 9361 werner.grauwiler@lonza.com
Kontakt:
Münchensteinerstrasse 38
4052 Basel
Weitere Informationen und Links:
Newsletter abonnieren
Auf diesem Link abonnieren Sie unseren Newsletter und sind stets aktuell informiert.
Eigene News publizieren
Haben Sie eine aktuelle Firmeninformation oder ein Angebot, dass Sie hier publizieren möchten?
Auf diesem Link erfassen Sie die entsprechenden Informationen.